v3.26.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2025
Summary of Significant Accounting Policies [Abstract]  
Schedule of Exchange Rates

Translation of amounts from RMB into US$ has been made at the following exchange rates for the respective periods:

 

    December 31,
2025
    December 31,
2024
 
Balance sheet items, except for equity accounts     6.9931       7.2993  

 

    For the Years Ended December 31,  
    2025     2024     2023  
Items in the statements of operations and comprehensive loss, and statements of cash flows     7.1875       7.1957       7.0809  
Schedule of Property and Equipment Estimated Useful Lives Depreciation is computed using the straight-line method with residual value rate of 5% based on the estimated useful lives as follows:
Land and buildings   7 - 21 years
Office equipment   3 years
Vehicle   4 years
Leasehold improvements   5 years
Schedule of Amortized Over their Estimated Useful Lives

Separately identifiable intangible assets that have determinable lives continue to be amortized over their estimated useful lives using the straight-line method based on their estimated useful lives as follows:

 

Trademarks   10 years
License   10 years
Software   3 - 10 years
Schedule of Disaggregation of Our Revenue

The following table identifies the disaggregation of our revenue for the years ended December 31, 2025, 2024 and 2023, respectively.

 

   For the Years Ended
December 31,
 
   2025   2024   2023 
Medical training and education services  $6,858,034   $7,704,812   $6,385,735 
Patient management services in patient-aid projects   3,820,520    6,008,152    4,020,999 
Sales of patented drugs   696,442    2,151,809    9,027,211 
Total  $11,374,996   $15,864,773   $19,433,945